Osteopontin expression correlates with clinical outcome in patients with mycobacterial infection
Citation
Gj. Nau et al., Osteopontin expression correlates with clinical outcome in patients with mycobacterial infection, AM J PATH, 157(1), 2000, pp. 37-42
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
AMERICAN JOURNAL OF PATHOLOGY
SICI code
0002-9440(200007)157:1<37:OECWCO>2.0.ZU;2-G
Abstract
Osteopontin (OPN) is a protein flat Is expressed in chronic Inflammatory di
seases including tuberculosis, and its deficiency predisposes to more sever
e mycobacterial Infections in mice. However, no reports have identified alt
ered OPN expression in, or correlated these alterations to, infections in h
umans. The data presented herein identify alterations in the tissue express
ion of OPN protein and describe an inverse correlation between these levels
and disease progression after inoculation of Mycobacterium bovis bacillus
Calmette-Guerin vaccine in humans. Patients with regional adenitis and good
clinical outcomes had abundant OPN in infected lymph nodes. This pattern o
f OPN accumulation was also observed in patients infected by M. avium-intra
cellulare. In contrast, patients with disseminated infection and histologic
ally ill-defined granulomas had no significant osteopontin accumulation in
infected lymph nodes; these patients had either deficiencies in the interfe
ron-gamma receptor 1 or idiopathic Immune defects, The level of OPN protein
expression was inversely correlated with disseminated infection and, of pa
rticular interest, with death of the patient. We conclude that osteopontin
expression correlates with an effective immune and inflammatory response wh
en humans are challenged by a mycobacterial infection and that osteopontin
contributes to human resistance against mycobacteria.